| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/24/2009 | US7507395 Include pH-sensitive fluorescent and fluorogenic 2',7'-dialkylfluorescein derivatives and associated nonfluorescent precursor compounds; malignancy, multidrug resistance, lysosome storage disease, corneal acidosis, ulcer disease, diabetic heart condition, or hyperglycemia |
| 03/24/2009 | CA2466877C Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 03/24/2009 | CA2407715C Diagnostics and therapeutics for macular degeneration-related disorders |
| 03/24/2009 | CA2376500C Allergen detection |
| 03/24/2009 | CA2356442C Nmr spectroscopic in vitro assay using hyperpolarization |
| 03/24/2009 | CA2356317C Method and apparatus for measuring sample by luminescence |
| 03/24/2009 | CA2354635C Sequencing method using magnifying tags |
| 03/24/2009 | CA2318479C G protein-related kinase mutants in essential hypertension |
| 03/24/2009 | CA2304260C Method for determining a concentration of target nucleic acid molecules, nucleic acid probes for the method and method for analyzing data obtained by the method |
| 03/24/2009 | CA2260991C Multiplex flow immunoassays with magnetic particles as solid phase |
| 03/24/2009 | CA2258802C Conjugates of an oligonucleotide/electronic conductor polymer with a molecule of interest, and their uses |
| 03/24/2009 | CA2231501C Method for precipitating nucleic acid with visible carrier |
| 03/24/2009 | CA2196175C Culture medium and device for detection and enumeration of enterobacteriaceae |
| 03/21/2009 | CA2603615A1 Methods of reducing viral infection and kits therefore |
| 03/21/2009 | CA2602876A1 Tissue culture and cloning things |
| 03/19/2009 | WO2009036427A2 Prostate cancer biomarkers |
| 03/19/2009 | WO2009036336A2 Biomarkers for motor neuron disease |
| 03/19/2009 | WO2009036332A1 Micrornas differentially expressed in cervical cancer and uses thereof |
| 03/19/2009 | WO2009036303A1 Finite and multiple sterilization indication method for devices |
| 03/19/2009 | WO2009036299A2 Compositions and methods for the identification of inhibitors of retroviral infection |
| 03/19/2009 | WO2009036257A1 Prediction of sleep parameter and response to sleep-inducing compound based on per3 vntr genotype |
| 03/19/2009 | WO2009036241A1 Live attenuated mycoplasma strains |
| 03/19/2009 | WO2009036236A1 Mirna expression in human peripheral blood microvesicles and uses thereof |
| 03/19/2009 | WO2009036119A1 Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule |
| 03/19/2009 | WO2009036100A2 Prediction of qt prolongation based on snp genotype |
| 03/19/2009 | WO2009036091A1 Apparatus, compositions and methods for rapid competitive homogeneous assay |
| 03/19/2009 | WO2009036070A1 Spores for the stabilization and on-site application of bacterial whole-cell biosensing systems |
| 03/19/2009 | WO2009036063A1 Pseudotyped retroviral vectors and methods of making and using them |
| 03/19/2009 | WO2009036056A1 Antipsychotic treatment based on snp genotype |
| 03/19/2009 | WO2009035955A1 Methods for detecting enterobacter sakazakii |
| 03/19/2009 | WO2009035954A1 Methods for detecting listeria monocytogenes |
| 03/19/2009 | WO2009035929A2 Cardiovascular and brain cell therapy using intracellular ryanodine receptor modulation by the estrogen receptor beta |
| 03/19/2009 | WO2009035792A1 Compositions, methods and systems for the simultaneous determination of parentage, identity, sex, genotype and/or phenotype and breed determination in animals |
| 03/19/2009 | WO2009035706A1 Infectious disease testing of menstrual fluid, endometrial /menstrual cells, amniotic fluid, umbilical cord blood or other samples |
| 03/19/2009 | WO2009035647A1 High-resolution molecular graphene sensor comprising an aperture in the graphene layer |
| 03/19/2009 | WO2009035574A1 Method for measuring mitochondrial membrane potential in vertebrate cells |
| 03/19/2009 | WO2009035560A1 Methods of using genetic markers and related epistatic interactions |
| 03/19/2009 | WO2009035554A2 Superior structure stability and selectivity of hairpin nucleic acid probes with an l-dna stem |
| 03/19/2009 | WO2009035402A1 Diagnosis of cancer by determining polymorphisms in blm, top3a or rmil |
| 03/19/2009 | WO2009035177A1 Genotyping of human papilloma viruses by multiplex amplification and size differentiation |
| 03/19/2009 | WO2009035170A1 Method for diagnosis and induction of resistance to virus |
| 03/19/2009 | WO2009035015A1 Method of reducing measurement error caused by catalase inhibition by azide |
| 03/19/2009 | WO2009034961A1 Method of evaluating human dendritic cells and human cell immunotherapeutic agent |
| 03/19/2009 | WO2009034945A1 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent |
| 03/19/2009 | WO2009034842A1 Nucleic acid detection method, and nucleic acid detection kit |
| 03/19/2009 | WO2009034790A1 Fluorescent molecule |
| 03/19/2009 | WO2009034779A1 Cancer diagnosis kit and cancer diagnosis method |
| 03/19/2009 | WO2009034661A1 Method for diagnosis and induction of resistance to virus |
| 03/19/2009 | WO2009034353A1 Imprinted array |
| 03/19/2009 | WO2009034284A1 Strip for an electrochemical meter |
| 03/19/2009 | WO2009034200A1 Novel amperometric biosensor, production method therefor and use of same |
| 03/19/2009 | WO2009034199A1 Genetic informativity study |
| 03/19/2009 | WO2009034181A2 Methods for the preparation of dna microarrays with linear high density probes |
| 03/19/2009 | WO2009034055A1 Method for predicting the response of a subject suffering from a viral infection of the liver to an antiviral therapy |
| 03/19/2009 | WO2009033941A1 A method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent |
| 03/19/2009 | WO2009033580A1 Generic kinase/phosphatase assay with single readout |
| 03/19/2009 | WO2009033411A1 Method and composition for cancer diagnosis and treatment |
| 03/19/2009 | WO2009033293A1 Protein tyrosine phosphatase 1b and cancer |
| 03/19/2009 | WO2009033282A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 03/19/2009 | WO2009014639A3 Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same |
| 03/19/2009 | WO2009013405A8 Human male fertility control using spata 16 |
| 03/19/2009 | WO2009012363A3 Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof |
| 03/19/2009 | WO2009012359A3 Matrix metalloprotease targeting nucleic acids |
| 03/19/2009 | WO2009011923A3 Method of identifying hydrogen evolving diazotrophic bacteria |
| 03/19/2009 | WO2009011888A3 Ruler arrays |
| 03/19/2009 | WO2009007726A3 Abnormal blood conditions |
| 03/19/2009 | WO2009004068A3 Androgen-dependent 1-f-aromatase reporter gene |
| 03/19/2009 | WO2008155692A3 Molecular conformation biosensing |
| 03/19/2009 | WO2008154098A3 Reagents and methods for mirna expression analysis and identification of cancer biomarkers |
| 03/19/2009 | WO2008148972A3 Reaction medium for identifying/detecting micro-organisms |
| 03/19/2009 | WO2008137089A3 Gene signature of early hypoxia to predict patient survival |
| 03/19/2009 | WO2008127363A3 Devices for generating detectable polymers |
| 03/19/2009 | WO2008117200A3 Integrated microfluidic device with reduced peak power consumption |
| 03/19/2009 | WO2008115419A3 Gene expression markers for prediction of patient response to chemotherapy |
| 03/19/2009 | WO2008109142A3 Pirna and uses related thereto |
| 03/19/2009 | WO2008104681A3 Bacteria detection and/or identification medium |
| 03/19/2009 | WO2008093002A3 Method for detection of presence of target polynucleotide in samples |
| 03/19/2009 | WO2008091288A3 Microbial synthesis of d-1,2,4-butanetriol |
| 03/19/2009 | WO2008065544A3 Genetic predictors of risk for type 2 diabetes mellitus |
| 03/19/2009 | WO2008054546A3 A method to identify disease resistant quantitative trait loci in soybean and compositions thereof |
| 03/19/2009 | WO2008021681A3 System and methods for analyzing images of tissue samples |
| 03/19/2009 | WO2008009852A3 Modulators of lanosterol synthetase in the treatment of acne or of hyperseborrhoea |
| 03/19/2009 | WO2007029200A9 Ssb - polymerase fusion proteins |
| 03/19/2009 | WO2006099184A3 Method of diagnosing gum disease-wound healing using single nucleotide polymorphism profiles |
| 03/19/2009 | WO2006034427A3 Diagnosis of fetal aneuploidy |
| 03/19/2009 | WO2006020933A3 Dual labeled fluorescent probes |
| 03/19/2009 | WO2005089122A3 Animals with reduced body fat and increased bone density |
| 03/19/2009 | WO2005077125A3 Methods and compositions for detecting nucleic acids |
| 03/19/2009 | WO2005076861A3 Compounds that inhibit hiv particle formation |
| 03/19/2009 | WO2005076785A3 Method and compositions for detecting botulinum neurotoxin |
| 03/19/2009 | WO2005074556A3 Netrin compositions and methods of use thereof |
| 03/19/2009 | WO2005074483A3 Genetic markers for skatole metabolism |
| 03/19/2009 | WO2005069987A3 Amplifying interfering rna (rnai) expression and effects |
| 03/19/2009 | WO2005060667A3 Nucleic acid and amino acid sequences involved in pain |
| 03/19/2009 | WO2005047451A3 Isolation of nucleic acid from mouth epithelial cells |
| 03/19/2009 | US20090077683 Watermelon line wnv142-1115 |
| 03/19/2009 | US20090077682 Tomato line fir 128-1018 |
| 03/19/2009 | US20090077681 Methods for Diagnosing and Treating Heart Disease |
| 03/19/2009 | US20090077677 Mammalian grainyhead transcription factors |
| 03/19/2009 | US20090077676 Prematurely ageing mouse models for the role of dna damage in ageing and intervention in ageing-related pathology |